Compare CVR & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVR | PFSA |
|---|---|---|
| Founded | 1920 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4M | 3.7M |
| IPO Year | 1995 | N/A |
| Metric | CVR | PFSA |
|---|---|---|
| Price | $13.57 | $0.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.7K | ★ 241.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.88% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $26,986,627.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.15 | $0.05 |
| 52 Week High | $15.00 | $4.22 |
| Indicator | CVR | PFSA |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 45.88 |
| Support Level | $13.32 | $0.85 |
| Resistance Level | $14.47 | $2.22 |
| Average True Range (ATR) | 0.51 | 0.13 |
| MACD | -0.02 | -0.08 |
| Stochastic Oscillator | 18.29 | 16.98 |
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.
Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.